Hyperhomocysteinemia is a risk factor for a number of neurodegenerative and cardiovascular diseases. We
have shown that homocysteine induces excitotoxic effects in cells expressing glutamate receptors of the NMDA class.
These receptors were found not only in neurons but also in immune-competent cells, neutrophils, red blood cells, cardiomyocytes,
and osteoblasts. Activation of these cells by homocysteine results in an increase in cytoplasmic calcium ions,
accumulation of reactive oxygen species, and activation of MAP kinase. An overload of immune-competent cells activates
both necrotic and apoptotic cell death, whereas the neuropeptide carnosine (an antioxidant and immune modulator) protects
cells against both processes. In a model of prenatal hyperhomocysteinemia in rats, we have found that carnosine protects
animals against homocysteine toxicity with no change of the blood homocysteine levels. The efficiency of carnosine
has also been demonstrated in clinical trials of chronic brain ischemia and Parkinson’s disease.
Keywords: Homocysteine, homocysteic acid, NMDA receptors, neurons, immune competent cells, carnosine.
Rights & PermissionsPrintExport